Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Servicios Integrados de Salud (IHS): Una Intervención Estructural para Mejorar el Cribado de VIH/ITS y la Navegación de la PrEP en Atención Primaria (IHS)

12 de noviembre de 2026 actualizado por: June Gipson, My Brother's Keeper, Inc.

Integrated Health Services (IHS): Una intervención estructural para mejorar el cribado del VIH/ITS y la navegación hacia la PrEP en atención primaria

The goal of this clinical trial is to learn whether integrating routine, opt-out HIV and STI testing and pre-exposure prophylaxis (PrEP) navigation into primary care increases use of these services among adults ages 18 to 45 receiving care at Federally Qualified Health Centers in Mississippi. The main questions it aims to answer are:

  1. Does the integrated model increase HIV and STI testing compared with standard care?
  2. Does the integrated model increase PrEP navigation activity for eligible patients?
  3. How do patients and clinic staff experience the integrated model in terms of satisfaction, comfort discussing sexual health, and feasibility in daily workflows?

Researchers will compare a standard-care period to a period when the integrated model is in place to see if the integrated model improves service use and patient experience.

Participants will:

  1. Receive usual primary care, with HIV/STI testing and PrEP discussions offered as a routine, opt-out part of care during the integrated period
  2. Be invited, if eligible, to complete a brief survey about their clinic experience
  3. For staff, be invited to take part in a short survey or interview about clinic workflows and the integrated model

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

This is a quasi-experimental, mixed-methods implementation study designed to evaluate an integrated sexual and reproductive health (SRH) model that embeds routine, opt-out HIV and sexually transmitted infection (STI) testing and pre-exposure prophylaxis (PrEP) navigation into primary care workflows at two Federally Qualified Health Centers (FQHCs) in Canton and Yazoo City, Mississippi. The study focuses on adults ages 18-45 receiving primary care at participating clinics, a population experiencing high HIV/STI burden and structural barriers to SRH services, including limited routine testing, low PrEP uptake, and fragmented referral pathways. The intervention is informed by the Comprehensive Theory of Integration and aims to normalize HIV/STI testing as part of routine care while strengthening PrEP navigation and care coordination within existing clinic infrastructure.

The intervention operates at the clinic and workflow level rather than at the level of individual randomization. During the standard-care period, HIV/STI testing and PrEP discussions occur based on provider discretion or patient request, supported by existing electronic health record (EHR) prompts. During the integrated-care period, the study implements standing orders for nurses and peer navigators to initiate HIV tests, guideline-aligned STI tests, and PrEP navigation for eligible patients; EHR prompts and templates that cue providers to offer testing and PrEP in an opt-out manner; embedded peer navigation and daily team huddles to support linkage and follow-up; and training and technical assistance to promote culturally responsive, stigma-informed care. These changes are designed to be feasible within typical FQHC staffing and technology constraints.

The study uses a 24-month pre-post design, with a 12-month standard-care phase followed by a 12-month integrated-care phase. Primary quantitative data will be derived from de-identified or limited EHR extracts containing variables such as age, sex, race/ethnicity, visit type, HIV/STI test ordering and completion, PrEP offers and navigation steps, and documented declinations. Additional quantitative data will be collected through brief patient surveys assessing visit experience, satisfaction, comfort discussing sexual health, perceptions of opt-out testing, and experiences with PrEP discussions and navigation. Qualitative data will be obtained via semi-structured key-informant interviews and surveys with medical providers, nurses/medical assistants, patient navigators and community health workers, and clinic administrators, as well as interviews with a subset of patients, to explore implementation processes, barriers and facilitators, perceived impact, and sustainability.

No experimental drugs or devices are used, and all HIV/STI testing and PrEP services adhere to current clinical guidelines as part of routine care. The research procedures consist of (1) implementing and monitoring the integrated workflow; (2) abstracting EHR data under an IRB-approved waiver of consent and, where applicable, HIPAA authorization; and (3) collecting survey and interview data from patients and staff under informed consent. The primary implementation outcome is change in HIV/STI test uptake among adults ages 18-45 between the standard-care and integrated-care periods. Secondary outcomes include changes in PrEP navigation activity, patient-reported satisfaction and comfort discussing sexual health, provider adoption and fidelity to integrated SRH workflows, and feasibility and acceptability of the intervention from staff and patient perspectives. Analytic plans include pre-post comparisons of service uptake and navigation metrics, as well as thematic analysis of qualitative data to identify contextual factors (e.g., staffing, workflow, stigma, policy environment) that influence successful integration and scalability of the model in high-need FQHC settings.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

700

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Edna S Lampkin, Pharm D.
  • Número de teléfono: 216 769-216-2455
  • Correo electrónico: elampkin@mbk-inc.org

Copia de seguridad de contactos de estudio

  • Nombre: June A Gipson, PhD
  • Número de teléfono: 101 769-216-2455
  • Correo electrónico: jgipson@mbk-inc.org

Ubicaciones de estudio

    • Mississippi
      • Ridgeland, Mississippi, Estados Unidos, 39157
        • My Brother's Keeper, Inc.
        • Contacto:
          • June a Gipson, PhD
          • Número de teléfono: 101 769-216-2455
          • Correo electrónico: jgipson@mbk-inc.org
        • Contacto:
          • Edna Lampkin, Pharm D.
          • Número de teléfono: 216 7692162455
          • Correo electrónico: elampkin@mbk-inc.org
        • Investigador principal:
          • June A Gipson, PhD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 45 años (Adulto)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Adults ages 18 to 45 years.
  • Receiving primary care services at participating Federally Qualified Health Center (FQHC) clinics in Canton or Yazoo City, Mississippi.
  • Able to understand and read English (for participation in surveys and interviews).
  • For staff key informants: current clinical, administrative, or support role at a participating FQHC site with responsibilities related to primary care, HIV/STI services, or care coordination.

Exclusion Criteria:

  • Younger than 18 years or older than 45 years.
  • Critically ill, psychiatrically unstable, or lacking capacity to provide informed consent for research participation.
  • Unable to understand English for consent and survey/interview procedures.
  • For staff key informants: unable or unwilling to provide informed consent for interviews or surveys.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Investigación de servicios de salud
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Sin intervención: Standard Care

Usual care delivered before implementation of the Integrated Health Services (IHS) model. HIV/STI testing and PrEP navigation occur at provider discretion without standardized workflows or EHR prompts. This represents the 12-month pre-intervention period.

Experimental: Integrated HIV/STI and PrEP Care

Care delivered during the 12-month intervention period using the Integrated Health Services (IHS) model, which incorporates routine opt-out HIV/STI screening, standing orders, EHR prompts, and standardized PrEP navigation workflows

Clinic-level implementation of an integrated sexual and reproductive health model that embeds routine, opt-out HIV and sexually transmitted infection (STI) testing and pre-exposure prophylaxis (PrEP) navigation into primary care at Federally Qualified Health Centers. The intervention includes: (1) standing orders for nurses and peer navigators to initiate HIV/STI testing and PrEP navigation for eligible adults ages 18-45; (2) enhanced electronic health record prompts and templates to support opt-out testing and documentation of offers, completions, and declinations; (3) embedded peer navigation and daily team huddles to coordinate linkage and follow-up; and (4) training and technical assistance for clinic staff on workflows, cultural responsiveness, and stigma-reduction related to sexual health and PrEP.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
HIV Testing Uptake
Periodo de tiempo: 12 months during standard-care period and 12 months during integrated-care period

Proportion of primary care visits among adults ages 18-45 at participating FQHC clinics with an HIV test completed (numerator: visits with HIV test completed; denominator: eligible visits for adults 18-45), comparing the standard-care period to the integrated-care period using electronic health record data.

12 months during standard-care period and 12 months during integrated-care period

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
STI Testing Uptake
Periodo de tiempo: 12 months during standard-care period and 12 months during integrated-care period

Proportion of primary care visits among adults ages 18-45 with at least one guideline-aligned STI test (e.g., chlamydia, gonorrhea, syphilis) completed, comparing the standard-care period to the integrated-care period using electronic health record data.

12 months during standard-care period and 12 months during integrated-care period
PrEP Navigation Activity
Periodo de tiempo: 12 months during standard-care period and 12 months during integrated-care period

Proportion of eligible adult patients ages 18-45 with a documented PrEP offer and/or navigation step (e.g., referral, navigation contact, PrEP prescription) during primary care visits, comparing standard-care and integrated-care periods using electronic health record data.

12 months during standard-care period and 12 months during integrated-care period
Patient Satisfaction With Integrated Care
Periodo de tiempo: Within 7 days of an index primary care visit during the integrated-care period

Mean composite score on the patient satisfaction survey completed by adults ages 18-45 after a primary care visit during the integrated care period.

Within 7 days of an index primary care visit during the integrated-care period
Staff Feasibility Rating
Periodo de tiempo: At 6 and 12 months after initiation of the integrated-care period

Mean feasibility rating score from staff surveys assessing feasibility of the integrated-care workflows.

At 6 and 12 months after initiation of the integrated-care period
Staff Acceptability Rating
Periodo de tiempo: Assessed at 6 months and 12 months after initiation of the integrated care period.

Mean acceptability rating score from staff surveys evaluating the acceptability of integrated workflows, including perceived usefulness, appropriateness, and value among providers, nurses/medical assistants, navigators, and administrators.

Assessed at 6 months and 12 months after initiation of the integrated care period.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: June A Gipson, PhD, My Brother's Keeper, Inc.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de mayo de 2027

Finalización primaria (Estimado)

30 de abril de 2028

Finalización del estudio (Estimado)

1 de agosto de 2028

Fechas de registro del estudio

Enviado por primera vez

10 de febrero de 2026

Primero enviado que cumplió con los criterios de control de calidad

27 de febrero de 2026

Publicado por primera vez (Actual)

3 de marzo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • MBK-IHS-01
  • 3OT2OD035877-01S2 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

De-identified individual participant data (IPD) that underlie the primary and secondary outcome results (selected EHR variables for adults ages 18-45 and de-identified patient and staff survey responses) will be shared. No direct identifiers or HIPAA-defined identifiers will be included, and small cells will be handled to reduce re-identification risk. IPD will be available within 12 months after publication of the main study findings and for at least 5 years thereafter. Data will be shared with qualified researchers who have a scientifically sound proposal, appropriate ethics/IRB approval, and a signed data use agreement with My Brother's Keeper, Inc. and partner clinics. Data will be provided via secure, encrypted transfer or a controlled-access repository.

Marco de tiempo para compartir IPD

De-identified IPD and supporting documents will be available beginning within 12 months after publication of the primary study results in a peer-reviewed journal or submission of the main results to ClinicalTrials.gov, whichever occurs first. Data will remain available for at least 5 years after initial release, or longer if required by funder or institutional policies. Requests received after that period may be considered on a case-by-case basis depending on data retention and feasibility.

Criterios de acceso compartido de IPD

De-identified IPD will be shared with qualified researchers at academic, clinical, or public health institutions for analyses that are consistent with the original study aims (for example, secondary implementation, health services, or equity-focused analyses) or address clearly justified, related scientific questions. Requestors must submit a brief research proposal, analysis plan, and evidence of IRB/ethics approval or exemption. Requests will be reviewed by the Principal Investigator and designated study leadership at My Brother's Keeper, Inc. and collaborating institutions to assess scientific merit, feasibility, and consistency with participant privacy protections and data-use agreements. Approved requestors will sign a data-use agreement that prohibits any attempt at re-identification and limits data use to the approved project. Data will be provided via secure, encrypted transfer or a controlled-access data repository.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .